Ledger.Open graph →
SEC Form D · filed October 31, 2024

Garuda Therapeutics, Inc

Offering
—
Sold
$47.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

David M. Carver · Cambridge, MAExec · DirectorGeoff Meyerson · Cambridge, MADirectorRaymond Kelleher · Cambridge, MADirectorEric Aguiar · Cambridge, MADirectorSteve Liapis · Cambridge, MADirectorRahul Singhvi · Cambridge, MADirectorDavid Kirske · Cambridge, MAExecCarl Gordon · Cambridge, MADirectorAdam Craig · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗